| MONOMETHYL FUMARATE | None | ||
| 95MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| BAFIERTAM is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease,in adults | |||
|
Yes
| |||
| BAFIERTAM | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||
| ********** ******* ******** ****** | ********** ******* ******** ****** | ******** ***** ************** ************ | ******** ***** ************** ************ | ******** ***** ****** ***** | ******** ***** ****** ***** | ******** ***** ****** ***** | ******** ***** ************** ************ | ******** ***** ****** ***** | ******** ***** ************** ************ | ******** ***** ****** ***** | ******** ****** | ******** ***** ****** ***** | ******** ***** ************** ************ | ******** ***** ************** ************ | ******** ****** | ******** ***** ************** ************ | ******** ***** ************** ************ | ******** ***** ****** ***** | ******** ***** ****** ***** | ******** ***** ****** ***** **** ******** **************** ************ |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|